drugset / Trial / NCT01144650
Dapsone for Acute Ischemia Stroke Study
Phase 2/3
Unknown
300 enrolled
Cidat, S.A. de C.V.
El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez · collab
RandomizedParallel-groupTriple-blindPrevention
Summary
The main purpose of the study is to get information about the safety and efficacy of treatment with Dapsone to prevent the disability after ischemic Stroke, in patients diagnosed with anterior territory brain infarct.
Timeline
- Start
- 2009-07
- Primary completion
- 2010-08
- Completion
- 2010-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dapsone | Small molecule | 250 mg | Intravenous |